Concepedia
Statistics
Publications
15
Citations
1.5K
H-Index
12
Active since
2005
Affiliations
Dana-Farber Cancer Institute(Current)
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Brigham and Women's Hospital
Harvard University
J. A. Meyerhardt is an author at Dana-Farber Cancer Institute specializing in cancer therapeutics, oncology, and cancer research.
Top concepts
MedicineOncologyCancer TherapyPathologyCancer ResearchRadiation OncologyPharmacologyPharmacotherapyMolecular OncologyImmunology
Publications per year
2005–2014
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino, Katsuhiko Nosho, Gregory J. Kirkner et al. · Gut · 2008 · 777 citations · Full text
Molecular correlates with <i>MGMT</i> promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer
Shuji Ogino, Gregory J. Kirkner, J. A. Meyerhardt et al. · Gut · 2007 · 112 citations · Full text
Chemotherapy Usage Patterns in a US-Wide Cohort of Patients With Metastatic Colorectal Cancer
Thomas A. Abrams, Gary Meyer, Deborah Schrag et al. · JNCI Journal of the National Cancer Institute · 2014 · 110 citations
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
Jennifer A. Chan, Lawrence S. Blaszkowsky, Peter C. Enzinger et al. · Annals of Oncology · 2011 · 107 citations · Full text
Advanced Esophageal, Single-agent Cetuximab, Esophagus +11
A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors
Matthew H. Kulke, Keith Stuart, Craig C. Earle et al. · Journal of Clinical Oncology · 2006 · 92 citations
Pathology, Phase Ii Study, Pharmacotherapy +19
1–5 of 15